// App-Quantinova.ai

POS0175 (2021) : ASSOCIATION BETWEEN BIOMARKERS AND THERAPEUTIC PATHWAY IN PATIENTS WITH SLE

Researchers

Presenter

  • S. U. Hassan

Principal Investigators

  • K. Mahmoud

  • Z. Wigston

  • A. Burska

  • M. Y. MD Yusof

  • E. Vital

Medical Centers

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK

  • Leeds Musculoskeletal Biomedical Research Unit, The Leeds Teaching Hospital NHS, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Rituximab

  • IFN-lambda

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Roche

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved